Skip to content

Sedation and Anesthesia for GI Endoscopy in Frail Elderly Patients: a prospective, randomized, controlled trial

Sedation and Anesthesia for GI Endoscopy in Frail Elderly Patients: a prospective, randomized, controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060378
Enrollment
Unknown
Registered
2022-05-30
Start date
2022-06-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

frailty

Interventions

Group 1:
Group 2:

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age over 65 years old, gender is not limited; 2. The ASA classification is II, III; 3. BMI 18-28 kg/m2; 4. Patients receiving examination or treatment outside the operating room; 5. Score on the Simple Frailty Questionnaire (FRAIL) and/or Modified Frailty Index (mFI) >= 3 points; 6. Patients voluntarily participated in this study and signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic or contraindicated to benzodiazepines, opioids, propofol and other drugs and their drug components; 2. Acute heart failure; unstable angina; myocardial infarction within 6 months before screening; resting ECG heart rate = 470 ms, female >= 480 ms; grade III atrioventricular stagnation; severe heart rhythm abnormality; moderate to severe heart valve disease; 3. Patients with severe respiratory diseases (acute respiratory infection, acute exacerbation of chronic obstructive pulmonary disease, uncontrolled asthma, etc.); 4. Patients who have not received formal antihypertensive treatment or poorly controlled blood pressure; 5. Craniocerebral injury, possible intracranial hypertension, cerebral aneurysm, history of cerebrovascular accident, and central nervous system disease; 6. Suffering from psychiatric diseases (schizophrenia, mania, bipolar disorder, insanity, etc.) and long-term use of psychotropic drugs and cognitive dysfunction; 7. Other conditions judged by the researchers to be unsuitable for inclusion.

Design outcomes

Primary

MeasureTime frame
hypotension;

Secondary

MeasureTime frame
respiratory depression;recovery time;injection pain;bradycardia;

Countries

China

Contacts

Public ContactDan Cheng

The First Affiliated Hospital of Zhengzhou University

chengdan0607@163.com+86 371 66278576

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026